Sign in
4

Changes in Ownership

Nuvectis Pharma, Inc. Filed Acc 0001104659-23-081834

Chairman & CEO bought 260 shares at an average $15.52 ($4,035)

From the SEC's structured data for this filing

Trades in this filing

BENTSUR RON · Chairman & CEO

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2023-07-07 Purchase : show line 1 in the form +110 $16.19 $1,781 3,231,209 D
2023-07-14 Purchase : show line 2 in the form +150 $15.03 $2,255 3,231,359 D
Open-market purchases · 260 sh · avg $15.52 · $4,035
Loading xslF345X05/tm2321526-1_4seq1.xml…